ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 157

$606K Total Retail Price of All Prescriptions

Rank: 35 out of 157

256 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Delaware
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 256 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 256 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $83 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Delaware
ATORVASTATIN CALCIUM 330 232 67 1 3
PRAVASTATIN SODIUM 240 176 62 2 9
METFORMIN HCL 226 161 55 3 8
LEVOTHYROXINE SODIUM 223 162 42 4 1
LISINOPRIL 166 111 45 5 2
OMEPRAZOLE 155 104 38 6 6
FUROSEMIDE 135 90 35 7 7
CRESTOR 133 76 22 8 14
GABAPENTIN 129 86 33 9 16
LOSARTAN POTASSIUM 127 85 26 10 18
SIMVASTATIN 119 106 33 11 4
ZOLPIDEM TARTRATE 112 61 21 12 20
TRAMADOL HCL 111 73 29 13 17
PANTOPRAZOLE SODIUM 105 77 20 14 44
CLONAZEPAM 101 80 31 B 15 55
ALPRAZOLAM 93 52 16 B 16 11
BISOPROLOL FUMARATE 91 78 22 17 72
GLIMEPIRIDE 90 59 19 18 24
CLOPIDOGREL 89 65 16 19 21
METOPROLOL SUCCINATE 85 48 18 20 12
CARVEDILOL 82 58 20 21 23
ENALAPRIL MALEATE 81 68 14 22 127
CYMBALTA 80 28 14 23 46
AMLODIPINE BESYLATE 78 57 20 24 5
IPRATROPIUM BROMIDE 75 60 54 25 211
SPIRIVA 70 45 16 26 47
BISOPROLOL-HYDROCHLOROTHIAZIDE 69 <11 <11 27 114
ROPINIROLE HCL 69 30 11 27 118
PREDNISONE 68 48 29 29 35
ZETIA 68 36 14 29 68
ADVAIR DISKUS 66 61* 17 31 50
TAMSULOSIN HCL 65 60* 15 32 32
NEXIUM 65 28 16 32 30
MIRTAZAPINE 58 53* 14 34 37
ESCITALOPRAM OXALATE 57 52* 11 35 42
CITALOPRAM HBR 55 50* 21 36 29
MELOXICAM 55 18 19 36 62
NOVOLOG FLEXPEN 54 <11 <11 38 80
AZITHROMYCIN 54 40 38 38 36
SPIRONOLACTONE 52 <11 <11 40 109
ALENDRONATE SODIUM 51 <11 <11 41 48
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.